These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The antiarrhythmic effects of d-sotalol. Schwartz J; Crocker K; Wynn J; Somberg JC Am Heart J; 1987 Sep; 114(3):539-44. PubMed ID: 3630894 [TBL] [Abstract][Full Text] [Related]
6. Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group. Singh BN; Kehoe R; Woosley RL; Scheinman M; Quart B Am Heart J; 1995 Jan; 129(1):87-97. PubMed ID: 7817931 [TBL] [Abstract][Full Text] [Related]
7. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents. Nademanee K; Singh BN Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias. Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854 [TBL] [Abstract][Full Text] [Related]
9. Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation. Yu WC; Chen SA; Tai CT; Wen ZC; Feng AN; Ding YA; Chang MS Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2064-9. PubMed ID: 9826857 [TBL] [Abstract][Full Text] [Related]
10. Facilitation of ventricular tachycardia initiation by procainamide during programmed ventricular stimulation in patients with heart failure. Stevenson WG; Weiss J; Stevenson LW; Tillisch JH J Electrocardiol; 1990 Jan; 23(1):77-83. PubMed ID: 2406361 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram. Steinbeck G; Bach P; Haberl R J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368 [TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias. Kehoe RF; Zheutlin TA; Dunnington CS; Mattioni TA; Yu G; Spangenberg RB Am J Cardiol; 1990 Jan; 65(2):58A-64A; discussion 65A-66A. PubMed ID: 2294689 [TBL] [Abstract][Full Text] [Related]
14. Termination of ventricular tachycardia: role of tachycardia cycle length. Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712 [TBL] [Abstract][Full Text] [Related]
15. Procainamide in the induction and perpetuation of ventricular tachycardia in man. Kang PS; Gomes JA; El-Sherif N Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence. Lee SD; Newman D; Ham M; Dorian P J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301 [TBL] [Abstract][Full Text] [Related]
17. Intravenous Procainamide for Predicting the Response of Sustained Ventricular Tachycardia to Type III Antiarrhythmic Drugs. Snow JS; Cohen MB; Jadonath RL; Cohen TJ J Invasive Cardiol; 1997 Jan; 9(1):40-44. PubMed ID: 10762873 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias. Kühlkamp V; Mermi J; Mewis C; Seipel L J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]